← Back to Search

SPIRIT-in person for Dementia

N/A
Waitlist Available
Led By Mi-Kyung Song, PhD
Research Sponsored by Emory University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, up to 12 months post-intervention
Awards & highlights

Study Summary

This trial will adapt and pilot test an efficacious advance care planning interventions, SPIRIT (Sharing Patient's Illness Representations to Increase Trust), with patients with mild dementia and their surrogates to promote open, honest discussions while such discussions about end-of-life care are possible.

Eligible Conditions
  • Dementia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, up to 12 months post-intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, up to 12 months post-intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Dyad Congruence With Goals-of-Care Tool
Surrogate's Decision Making Confidence (DMC) Scale Score Among Phase II Participants
Surrogate's Overall Preparedness Scale
Secondary outcome measures
Completion of Advance Directives Among Phase II Participants
Patient's Overall Preparedness Scale

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: SPIRIT-remoteExperimental Treatment1 Intervention
Patients and surrogates who participate in the SPIRIT intervention remotely, via teleconference.
Group II: SPIRIT-in personExperimental Treatment1 Intervention
Patients and surrogates who participate in the SPIRIT intervention in person.
Group III: Usual careActive Control1 Intervention
Patients and surrogates who receive the standard information about advance directives that is provided at the time of diagnosis.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
SPIRIT-in person
2018
N/A
~250
SPIRIT-remote
2018
N/A
~250

Find a Location

Who is running the clinical trial?

Emory UniversityLead Sponsor
1,638 Previous Clinical Trials
2,560,290 Total Patients Enrolled
20 Trials studying Dementia
2,594 Patients Enrolled for Dementia
National Institute on Aging (NIA)NIH
1,672 Previous Clinical Trials
28,018,421 Total Patients Enrolled
266 Trials studying Dementia
23,625,118 Patients Enrolled for Dementia
Mi-Kyung Song, PhDPrincipal Investigator - Emory University
Emory University
2 Previous Clinical Trials
252 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is it currently feasible to apply for this clinical trial?

"Per records on clinicaltrials.gov, recruitment for this particular trial has since closed since its initial posting date of May 4th 2018 and most recent edit made on September 29th 2022. However, there are still 394 other trials actively recruiting patients at the moment."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Preparation for End-of-Life Decision Making in Mild Dementia
Mi-Kyung Song 2018. "Preparation for End-of-Life Decision Making in Mild Dementia". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03311711.
~35 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top